NuVasive Recalls Orthopedics Implants Over Biocompatibility Concerns
Executive Summary
The US FDA says the company has voluntarily issued a recall for Precice metal implants after reports of adverse events that could be related to the design of the product or biocompatibility issues.
You may also be interested in...
NuVasive Selling Titanium-Based Precice Orthopedic Devices Again, Launches Recall To Update IFU
NuVasive Inc. is marketing its Precice specialized orthopedic devices made of titanium once again after voluntarily pulling them from the market in April over concerns about the safety of the steel-based version of the product. The firm also initiated a recall to address changes in the instructions for use for titanium Precice.
NuVasive MAGEC Devices To Return To US Market Despite Safety Concerns
The FDA said the benefits of the devices, which are used to prevent spinal deformity in children with thoracic insufficiency syndrome, outweigh their known risks.
New FDA Site Walks Sponsors Step-By-Step Through Biocompatibility Requirements
The agency has developed a user-friendly four-step process sponsors can use to address biocompatibility issues based on its 2016 biocompatibility guidance.